Researchers explore the potential of immune checkpoint inhibitors before surgery to prevent recurrence in several cancers.

by Kendall K. Morgan

PSMA-targeted therapy, which delivers radiation directly to cancer cells, provides a new approach for those whose prostate cancer stops responding to other treatments.

by Stephen Ornes

Survivor Profile

Since a 2018 liver transplant for her inoperable cancer, Lorrinda Gray-Davis has devoted herself to organ transplant advocacy and outreach.

by Sharon Tregaskis

Healthy Habits

Adding calcium-rich foods to your diet may reduce colorectal cancer risk.

by Anne Danahy

Tailored treatments led to better outcomes than standard of care when biomarker results from liquid biopsy and tumor tissue aligned.

by Eric Fitzsimmons

While mRNA vaccines offer a personalized approach to triggering an immune response, peptide vaccines could be a one-size-fits-all treatment. Researchers are exploring both options.

by Thomas Celona

U.S. breast cancer deaths declined for women ages 20 to 49, which researchers credit to wider screening and better treatment.

by Kevin McLaughlin

Combining an immune checkpoint inhibitor with standard care extended event-free survival by nearly two years.

by Thomas Celona

A clinical trial finds a topical gel can decrease acneiform rash and improve quality of life in people being treated for colorectal cancer.

by Thomas Celona

The test, which analyzes urine for 18 cancer-specific genes, ruled out the need for biopsy in men with elevated PSA without a digital rectal exam.

by Sandra Gordon